Home » remaining

remaining

Atrys Health will sell the remaining 75% to its subsidiary Conversia when the market improves

Recent News Spanish pharmaceutical company Atrys Health will sell the remaining 75% to its subsidiary Conversia when the market improves. At the end of the year, the company announced the sale of 25% of that subsidiary to the company Arraigo NW Segundo for 20 million euros with the intention of focusing on the inorganic growth …

Atrys Health will sell the remaining 75% to its subsidiary Conversia when the market improves Read More »

Scroll to Top